In 867,689 Danish women, those vaccinated against HPV at 16 or younger had a cervical cancer rate 0.14 times that of unvaccinated women; vaccination at 20 to 30 showed no immediate effect.
Published as "Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer". The study included women aged 17 to 30 living in Denmark from October 2006 to December 2019, took vaccination and cervical cancer diagnoses from nationwide registries, and estimated incidence rate ratios by age at vaccination, adjusted for attained age, education and ethnicity, with a one-year buffer period in the primary analysis.
Population evidence from Denmark's linked registers that HPV vaccination given before 20 prevents cervical cancer, and that vaccinating early matters.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/